Background: Amongst the newly proposed biomarkers for ovarian cancer, serum human epididymis protein 4 (HE4) shows the greatest potential for clinical use. However, systematic appraisals of its biological characteristics are not available. This study sought to critically revise the available literature on biological and lifestyle factors affecting HE4 concentrations in serum to understand their possible influence on the marker interpretation. Methods: A literature search was undertaken on electronic databases and references from retrieved articles. Article results were analyzed by evaluating study design, sample size, statistical approach, employed assay and, when available, by collecting similar information for carbohydrate antigen 125 (C...
Human epididymis protein 4 (HE4) is a member of the "four-disulfide core" family that comprises a he...
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaini...
Objective: To evaluate the role of the novel tumor marker human epididymal secretory protein E4 (HE4...
Background: Measurement of human epididymis protein 4 (HE4) in serum has recently been proposed for ...
Background: An increased focus on the biological behaviour of serum biomarkers for ovarian cancer, i...
Background Human epididymis protein 4 (HE4) measurements in serum have been proposed for improving t...
Elevated human epididymis secretory protein 4 (HE4) serum levels have been widely investigated in pa...
Background: Ovarian cancer remains a leading cause of death from gynecological malignancy. Early dia...
Background: The addition of human epididymis protein 4 (HE4) to carbohydrate antigen 125 (CA125) in ...
AIM: Although CA125 is the most widely used cancer marker in the diagnostic approach of pelvic masse...
The National Institute for Health and Clinical Excellence (NICE) guidelines have sparked hot debate ...
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cance...
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaini...
Human epididymis protein 4 (HE4) has received major attention as a potential tumor marker in epithel...
The objective of the present study was to investigate in healthy young women the fluctuations in ser...
Human epididymis protein 4 (HE4) is a member of the "four-disulfide core" family that comprises a he...
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaini...
Objective: To evaluate the role of the novel tumor marker human epididymal secretory protein E4 (HE4...
Background: Measurement of human epididymis protein 4 (HE4) in serum has recently been proposed for ...
Background: An increased focus on the biological behaviour of serum biomarkers for ovarian cancer, i...
Background Human epididymis protein 4 (HE4) measurements in serum have been proposed for improving t...
Elevated human epididymis secretory protein 4 (HE4) serum levels have been widely investigated in pa...
Background: Ovarian cancer remains a leading cause of death from gynecological malignancy. Early dia...
Background: The addition of human epididymis protein 4 (HE4) to carbohydrate antigen 125 (CA125) in ...
AIM: Although CA125 is the most widely used cancer marker in the diagnostic approach of pelvic masse...
The National Institute for Health and Clinical Excellence (NICE) guidelines have sparked hot debate ...
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cance...
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaini...
Human epididymis protein 4 (HE4) has received major attention as a potential tumor marker in epithel...
The objective of the present study was to investigate in healthy young women the fluctuations in ser...
Human epididymis protein 4 (HE4) is a member of the "four-disulfide core" family that comprises a he...
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaini...
Objective: To evaluate the role of the novel tumor marker human epididymal secretory protein E4 (HE4...